These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 29078759)

  • 21. The effect of diminazene, an angiotensin-converting enzyme 2 activator, on adenine-induced chronic kidney disease in rats.
    Abdelrahman AM; Ali BH; Ali H; Manoj P; Al-Suleimani Y
    Fundam Clin Pharmacol; 2023 Apr; 37(2):235-244. PubMed ID: 36300543
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cinacalcet versus standard treatment for chronic kidney disease: a protocol for a systematic review and meta-analysis.
    Sekercioglu N; Busse JW; Mustafa RA; Guyatt GH; Thabane L
    Syst Rev; 2016 Jan; 5():2. PubMed ID: 26729302
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Up-regulation of parathyroid hormone-related protein in folic acid-induced acute renal failure.
    Santos S; Bosch RJ; Ortega A; Largo R; Fernández-Agulló T; Gazapo R; Egido J; Esbrit P
    Kidney Int; 2001 Sep; 60(3):982-95. PubMed ID: 11532093
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spironolactone ameliorates arterial medial calcification in uremic rats: the role of mineralocorticoid receptor signaling in vascular calcification.
    Tatsumoto N; Yamada S; Tokumoto M; Eriguchi M; Noguchi H; Torisu K; Tsuruya K; Kitazono T
    Am J Physiol Renal Physiol; 2015 Dec; 309(11):F967-79. PubMed ID: 26336165
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of cinacalcet treatment on bone mineral metabolism, anemia parameters, left ventricular mass index and parathyroid gland volume in hemodialysis patients with severe secondary hyperparathyroidism.
    Torun D; Yildiz I; Micozkadioglu H; Nursal GN; Yigit F; Ozelsancak R
    Saudi J Kidney Dis Transpl; 2016 Jan; 27(1):15-22. PubMed ID: 26787561
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of Secondary Hyperparathyroidism Treatment on Improvement in Anemia: Results from the MBD-5D Study.
    Tanaka M; Yoshida K; Fukuma S; Ito K; Matsushita K; Fukagawa M; Fukuhara S; Akizawa T
    PLoS One; 2016; 11(10):e0164865. PubMed ID: 27764168
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of cinacalcet cessation on hyperparathyroidism in kidney transcaplant patients after long-term dialysis therapy.
    Nakai K; Fujii H; Yoshikawa M; Kono K; Yonekura Y; Goto S; Ishimura T; Takeda M; Fujisawa M; Nishi S
    Clin Exp Nephrol; 2015 Dec; 19(6):1184-8. PubMed ID: 25782729
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glibenclamide improves kidney and heart structure and function in the adenine-diet model of chronic kidney disease.
    Diwan V; Gobe G; Brown L
    Pharmacol Res; 2014 Jan; 79():104-10. PubMed ID: 24291534
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dynamics of cinacalcet use and biochemical control in hemodialysis patients: a retrospective New-user cohort design.
    Reams BD; Dluzniewski PJ; Do TP; Yue SV; Bradbury BD; Kshirsagar AV; Brookhart MA
    BMC Nephrol; 2015 Oct; 16():175. PubMed ID: 26510587
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rosiglitazone alleviates injury in rats with adenine‑induced chronic kidney disease.
    Huang Y; Lei Y; Zheng Z; Wang X; Hu M; Liu R; Yu X
    Mol Med Rep; 2013 Dec; 8(6):1831-5. PubMed ID: 24126724
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antihypertensive and renal protective effects of renin-angiotensin system blockade in uremic rats treated with erythropoietin.
    Lebel M; Rodrigue ME; Agharazii M; Larivière R
    Am J Hypertens; 2006 Dec; 19(12):1286-92. PubMed ID: 17161776
    [TBL] [Abstract][Full Text] [Related]  

  • 32. L/N-type calcium channel blocker cilnidipine ameliorates proteinuria and inhibits the renal renin-angiotensin-aldosterone system in deoxycorticosterone acetate-salt hypertensive rats.
    Toba H; Yoshida M; Tojo C; Nakano A; Oshima Y; Kojima Y; Noda K; Wang J; Kobara M; Nakata T
    Hypertens Res; 2011 Apr; 34(4):521-9. PubMed ID: 21270815
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Minimal impact of calcimimetics on the management of hyperparathyroidism in chronic dialysis.
    Brunaud L; Ngueyon Sime W; Filipozzi P; Nomine-Criqui C; Aronova A; Zarnegar R; Kessler M; Frimat L; Ayav C
    Surgery; 2016 Jan; 159(1):183-91. PubMed ID: 26476826
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Effect of Cinacalcet on Calcific Uremic Arteriolopathy Events in Patients Receiving Hemodialysis: The EVOLVE Trial.
    Floege J; Kubo Y; Floege A; Chertow GM; Parfrey PS
    Clin J Am Soc Nephrol; 2015 May; 10(5):800-7. PubMed ID: 25887067
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A dual blocker of endothelin A/B receptors mitigates hypertension but not renal dysfunction in a rat model of chronic kidney disease and sleep apnea.
    Morales-Loredo H; Jones D; Barrera A; Mendiola PJ; Garcia J; Pace C; Murphy M; Kanagy NL; Gonzalez Bosc LV
    Am J Physiol Renal Physiol; 2019 May; 316(5):F1041-F1052. PubMed ID: 30810064
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PTH-dependence of the effectiveness of cinacalcet in hemodialysis patients with secondary hyperparathyroidism.
    Akizawa T; Kurita N; Mizobuchi M; Fukagawa M; Onishi Y; Yamaguchi T; Ellis AR; Fukuma S; Alan Brookhart M; Hasegawa T; Kurokawa K; Fukuhara S
    Sci Rep; 2016 Apr; 6():19612. PubMed ID: 27071541
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of Etelcalcetide vs Cinacalcet on Serum Parathyroid Hormone in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism: A Randomized Clinical Trial.
    Block GA; Bushinsky DA; Cheng S; Cunningham J; Dehmel B; Drueke TB; Ketteler M; Kewalramani R; Martin KJ; Moe SM; Patel UD; Silver J; Sun Y; Wang H; Chertow GM
    JAMA; 2017 Jan; 317(2):156-164. PubMed ID: 28097356
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gender differences in adenine-induced chronic kidney disease and cardiovascular complications in rats.
    Diwan V; Small D; Kauter K; Gobe GC; Brown L
    Am J Physiol Renal Physiol; 2014 Dec; 307(11):F1169-78. PubMed ID: 25209863
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The renoprotective effect of the dipeptidyl peptidase-4 inhibitor sitagliptin on adenine-induced kidney disease in rats.
    Abdelrahman AM; Suleimani YA; Za'abi MA; Ashique M; Manoj P; Hartmann C; Nemmar A; Schupp N; Ali BH
    Biomed Pharmacother; 2019 Feb; 110():667-676. PubMed ID: 30553193
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The use of cinacalcet hinders the diagnosis of parathyroid carcinoma in a chronic dialysis patient: a case report.
    Takada D; Tsukamoto T; Fuse M; Kada S; Yanagita M
    BMC Nephrol; 2017 Oct; 18(1):315. PubMed ID: 29047366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.